Title : Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer.

Pub. Date : 2021 Feb 15

PMID : 32999231






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Osimertinib is the standard treatment for epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer. osimertinib epidermal growth factor receptor Homo sapiens
2 Osimertinib is the standard treatment for epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer. osimertinib epidermal growth factor receptor Homo sapiens
3 Treatment with other EGFR-TKIs after osimertinib-induced ILD may be an option for subsequent therapy. osimertinib epidermal growth factor receptor Homo sapiens